Chattem Concealed Carcinogen In Dexatrim, Suit Says

Law360, New York (May 1, 2012, 1:55 PM EDT) -- Drugmaker Chattem Inc. was struck with a putative class action Friday in California federal court accusing the company of falsely marketing its over-the-counter Dexatrim-brand weight loss pills as safe and effective while actively concealing a cancer-causing chemical ingredient.

A similar suit filed in Indiana federal court was dismissed in September for lack of standing, but the complaint lodged Friday by former Dexatrim user and California resident Joanne Arroyo alleges Chattem violated state statutes, including the Consumer Legal Remedies Act and Unfair Competition Law.

The complaint cites...
To view the full article, register now.




Case Information

Case Title

Arroyo v. Chattem, Inc.

Case Number



California Northern

Nature of Suit

Other Statutory Actions


Charles R. Breyer

Date Filed

April 27, 2012

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.